Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rhythm Pharmaceuticals buy Bank of America Co.

Start price
€20.80
01.08.23 / 50%
Target price
-
01.08.24
Performance (%)
97.12%
End price
€41.00
02.08.24
Summary
This prediction ended on 02.08.24 with a price of €41.00. The BUY prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals saw massive gains of 97.12%. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Rhythm Pharmaceuticals 6.500% 6.500% 78.992%
iShares Core DAX® 4.097% 1.280% 17.609%
iShares Nasdaq 100 5.110% -0.741% 32.406%
iShares Nikkei 225® 5.333% -0.280% 16.646%
iShares S&P 500 3.487% -0.006% 27.373%

Comments by Bank_of_America_Co_ for this prediction

In the thread Rhythm Pharmaceuticals diskutieren

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.
Ratings data for RYTM provided by MarketBeat

In the thread Trading Rhythm Pharmaceuticals
Prediction Buy
Perf. (%) 97.12%
Target price
Change
Ends at 01.08.24

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten